Analysts have slashed Senseonics Holdings' 12-month price target by 40%, signaling heightened caution on the medical device maker's execution path following its stock split, despite maintaining a bullish long-term revenue model.
Quantum computing firm IonQ moves to acquire semiconductor foundry SkyWater Technology and optical communications specialist Skyloom Global, aiming to create the industry's first vertically integrated quantum company and gain tighter control over its core technology stack.
InSilico Medicine Cayman TopCo's shares have rocketed over 60% in a month, forcing investors to scrutinize whether its AI-driven drug discovery promise can justify the momentum, especially against a backdrop of persistent losses and a negative book value.
As the market digests Coursera's recent merger, Udemy's fair value estimate remains anchored at $8.51 per share. While analysts make minor adjustments to growth and discount rate assumptions, investors are left weighing what catalysts could redefine the online learning stock's trajectory.
As the U.S. dollar softens, Airbnb's extensive international footprint positions it for a potential earnings boost, adding a new layer for investors to consider beyond core travel demand.
Gökçe Güven, CEO of rewards startup Kalder and a 2023 Forbes 30 Under 30 honoree, is charged with securities fraud, wire fraud, and visa fraud. Prosecutors allege she used falsified data to raise millions from investors.
After a period of significant volatility, Neogen Corporation (NEOG) is showing signs of a sustainable operational turnaround under new leadership, with its latest quarterly results beating expectations and prompting a rare guidance upgrade.
While Winter Storm Devin triggered JetBlue's late-December collapse, a closer look reveals a fragile operational system, concentrated network, and strained labor relations that pose significant ongoing risks for the airline and its investors.
With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
A deep dive into the mounting challenges facing Unity Software Inc., from eroding developer trust and fierce competition to financial pressures, as a prominent bear thesis gains traction among investors.
After a sharp post-earnings sell-off and insider sales, Power Solutions International (PSIX) faces a critical test. Investors are weighing near-term execution risks against the company's strategic positioning in the surging demand for data center power generation.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
DLocal Limited's third-quarter results reveal a payments platform hitting its stride, with total payment volume soaring 59% year-over-year to a record $10.4 billion. Strong performance in Latin America and strategic expansions underpin a compelling growth narrative for the emerging markets fintech.
ServiceNow stock rose nearly 1% on Monday, outperforming the broader market, after Goldman Sachs added the workflow software giant to its prestigious Conviction List, citing significant expansion potential into new enterprise software segments.
Despite a recent rally, analysts argue Dollar General's defensive business model, deep rural footprint, and focus on essentials position it for steady, long-term growth as a haven for value-conscious investors.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
Amid a challenging retail landscape, Target Corporation (TGT) is drawing attention from value investors who argue its depressed stock price and reliable dividend profile present a compelling opportunity for steady returns.
Stride, Inc., a leading provider of K-12 online education, has seen its stock price pressured by temporary operational challenges. However, a closer look reveals a fundamentally sound business trading at a significant discount to its historical valuation, with a robust recurring revenue model and a substantial share buyback program underway.
The banking, financial services, and insurance (BFSI) sector is poised for a pivotal transformation. As the initial wave of AI and cloud experimentation subsides, 2026 is emerging as the year the industry moves decisively toward operationalizing technology with robust governance, explainability, and compliance at its core.
